Finance and strategy professional with experience supporting M&A transactions, commercial due diligence, and investment decisions across the global biopharmaceutical industry.
I specialize in financial modeling, valuation, forecasting, and structured problem solving to support high-stakes strategic decisions.
At a Glance
- 10+ M&A and commercial diligence engagements
- $1B+ aggregate transaction value supported
- 20+ target assets evaluated across acquisition and partnership structures
- Experience advising Fortune 500 biopharmaceutical organizations